0001140361-17-046688.txt : 20171219
0001140361-17-046688.hdr.sgml : 20171219
20171219144234
ACCESSION NUMBER: 0001140361-17-046688
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171215
FILED AS OF DATE: 20171219
DATE AS OF CHANGE: 20171219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KRIEGSMAN STEVEN A
CENTRAL INDEX KEY: 0001197482
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15327
FILM NUMBER: 171263737
MAIL ADDRESS:
STREET 1: 2165 TECHNOLOGY DRIVE
CITY: SCHENECTADY
STATE: NY
ZIP: 12308
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CYTRX CORP
CENTRAL INDEX KEY: 0000799698
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 581642750
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11726 SAN VICENTE BOULEVARD
STREET 2: SUITE 650
CITY: LOS ANGELES
STATE: CA
ZIP: 90049
BUSINESS PHONE: 310-826-5648
MAIL ADDRESS:
STREET 1: 11726 SAN VICENTE BOULEVARD
STREET 2: SUITE 650
CITY: LOS ANGELES
STATE: CA
ZIP: 90049
4
1
doc1.xml
FORM 4
X0306
4
2017-12-15
0
0000799698
CYTRX CORP
CYTR
0001197482
KRIEGSMAN STEVEN A
11726 SAN VICENTE BLVD.
SUITE 650
LOS ANGELES
CA
90049
1
1
0
1
CEO
Chairman of the Board
CytRx Common Stock
2017-12-15
4
A
0
387597
1.75
A
387597
D
Stock Option (right to buy)
1.75
2017-12-15
4
A
0
208334
0
A
2027-12-14
CytRx Common Stock
208334
208334
D
On December 6, 2017, the Compensation Committee of the Board of Directors agreed to award Mr. Kriegsman under the 2008 Equity Incentive Plan, 387,597 restricted common shares at the stock's closing prince on December 15, 2017 (the "award date"). The restricted shares will vest in equal installments on the first three anniversaries of the award date.
The stock option vests monthly for 36 months in equal installments, beginning 15 January 2018, provided Reporting Person remains in continuous employ of Issuer, or the conditions for immediate vesting occur.
STEVEN A. KRIEGSMAN
2017-12-19